Riskpilot← Back to searchSign inGet full accessFRAMOVER AS
ASActiveOrg 922246580Korsnesvegen 37, 7633 FrostaOther human health activities n.e.c. · NACE 8699Est. 20190 employees
Revenue 2025
NOK 0
EBITDA margin
—
+18% vs 2024
Equity ratio
99.4%
Financial strength
Net profit 2025
NOK 57K
+233% vs 2024
| Revenue | NOK 0 | — |
| EBITDA | NOK -14K | +18% |
| Net profit | NOK 57K | +233% |
| Total assets | NOK 177 | +13% |
| Equity | NOK 176 | +100% |
| Employees | 0 | — |
Legal name
FRAMOVER AS
Org number
922246580
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
18. februar 2019
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Helhetlig helse og salg av produkter/tjenester som naturlig hører sammen med dette.
Address
Korsnesvegen 37, 7633 Frosta
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 86 | 0 | 36 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 12 | −38 | 24 | −12 | −12 | −17 | −14 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 12 | −38 | 24 | −12 | −12 | −17 | −14 |
| Net financials | −0 | −5 | −7 | −0 | −4 | −26 | 71 |
| Profit before tax | 12 | −43 | 17 | −12 | −15 | −43 | 57 |
| Tax | 3 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 9 | −43 | 17 | −12 | −15 | −43 | 57 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total assets | 44 | 156 | 92 | 36 | 30 | 0 | 0 |
| Equity | 39 | −3 | 14 | 1 | −14 | −57 | 0 |
| Long-term debt | 0 | 109 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 | 50 | 78 | 35 | 44 | 57 | 0 |
| Total debt | 5 | 159 | 78 | 35 | 44 | 57 | 0 |
EBITDA margin
-1384000.0%
This company
15.8%
Market median
-8759594% vs market
20192025
Equity ratio
99.4%
This company
38.2%
Market median
+160% vs market
20192025
Return on equity
32539.2%
This company
18.4%
Market median
+176743% vs market
20192025
Net profit margin
5726900.0%
This company
8.1%
Market median
+70702369% vs market
20192025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20192025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-20 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EK Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2026 | — | — | |
| Chairman | 2026 | — | — | |
| Chairman | 2019 | — | — | |
| Board of Directors | 2026 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Espen Kolden As | Company | 50.0% | 50.0% | 2024 |
Tyn As | Company | 50.0% | 50.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tyn As
FRAMOVER AS Board members of FRAMOVER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Espen Kolden | Chief Executive Officer | 0 companies |
| Linda Bøkestad Korsnes | Chairman | 0 companies |
| Mari Synnøve Sveen Steinehaugen | Chairman | 0 companies |
| Bjørn Torger Aulstad | Chairman | 0 companies |
| Knut Terje Korsnes | Board of Directors | 0 companies |